134 related articles for article (PubMed ID: 3230337)
21. [Comprehensive diagnosis of cancer of the ovaries].
Korsunskiĭ VN; Tarasenko IuI; Ostrovskaia EIu; Stupakov IA; Mironova SP
Med Radiol (Mosk); 1989 Aug; 34(8):51-6. PubMed ID: 2549327
[TBL] [Abstract][Full Text] [Related]
22. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
Zalutsky MR; Bast RC; Knapp RC
Int J Rad Appl Instrum B; 1989; 16(4):405-11. PubMed ID: 2777582
[TBL] [Abstract][Full Text] [Related]
24. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
[TBL] [Abstract][Full Text] [Related]
25. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
26. Immunoscintigraphy with 131I or 111In labelled OC 125 F(ab')2 fragments in patients with ovarian carcinoma.
Jiménez-Vicioso A; Torres M; Jiménez-Heffernan A; Grana MD; Latre JM; Llamas JM; Carreras JL; Mateo A
Int J Biol Markers; 1990; 5(4):159-65. PubMed ID: 2093731
[TBL] [Abstract][Full Text] [Related]
27. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
[TBL] [Abstract][Full Text] [Related]
28. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
Bischof-Delaloye A; Delaloye B; Buchegger F; Gilgien W; Studer A; Curchod S; Givel JC; Mosimann F; Pettavel J; Mach JP
J Nucl Med; 1989 Oct; 30(10):1646-56. PubMed ID: 2795205
[TBL] [Abstract][Full Text] [Related]
30. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody.
Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G
Rays; 1987; 12(1):67-71. PubMed ID: 3628863
[No Abstract] [Full Text] [Related]
31. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.
Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C
Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277
[TBL] [Abstract][Full Text] [Related]
32. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases].
Baum RP; Hertel A; Hör G
Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623
[TBL] [Abstract][Full Text] [Related]
33. Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients.
Pectasides D; Pateniotis K; Tzimis L; Trapalli X; Natsis P; Arapantoni P; Taylor-Papadimitriou J; Epenetos A; Koutsiouba P; Athanassiou A
Int J Cancer Suppl; 1988; 3():83-8. PubMed ID: 3209305
[TBL] [Abstract][Full Text] [Related]
34. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
Lamki LM; Patt YZ; Murray JL
Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
[No Abstract] [Full Text] [Related]
35. [Experimental study of tumor detection using 131I-labeled F (ab)2 fragments of monoclonal antibodies to CA 19-9 and CEA (IMACIS-1)].
Mitsuhashi N; Kazumoto T; Nakayama Y; Sugiyama S; Yamakawa M; Yonome I; Nakamura Y; Nagai T; Niibe H
Gan No Rinsho; 1989 Dec; 35(15):1753-8. PubMed ID: 2691716
[TBL] [Abstract][Full Text] [Related]
36. Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation.
Ballantyne KC; Perkins AC; Selby C; Wastie ML; Hardcastle JD
Eur J Surg Oncol; 1988 Oct; 14(5):393-8. PubMed ID: 3181442
[TBL] [Abstract][Full Text] [Related]
37. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.
Zalutsky MR; Knapp RC; Bast RC
Int J Rad Appl Instrum B; 1988; 15(4):431-7. PubMed ID: 3255739
[TBL] [Abstract][Full Text] [Related]
38. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
39. Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125.
Muto MG; Lepisto EM; Van den Abbeele AD; Knapp RC; Kassis AI
Am J Obstet Gynecol; 1989 Nov; 161(5):1206-12. PubMed ID: 2686446
[TBL] [Abstract][Full Text] [Related]
40. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
Hölting T; Schlag P; Georgi P
Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
